Every investor in DermTech, Inc. (NASDAQ:DMTK) should be aware of the most powerful shareholder groups. Large companies usually have institutions as shareholders, and we usually see insiders owning ...
DermTech, Inc. (NASDAQ: DMTK) (“DermTech”), a leader in precision dermatology enabled by a non-invasive skin genomics platform, announced today that DermTech management will present at the BTIG ...
SAN DIEGO--(BUSINESS WIRE)-- DermTech, Inc. (NASDAQ: DMTK) (DermTech or the Company), a leader in precision dermatology enabled by a non-invasive skin genomics technology, today announced additional ...
LA JOLLA, Calif.--(BUSINESS WIRE)--DermTech, Inc. (NASDAQ:DMTK) (“DermTech”), a leader in precision dermatology enabled by a non-invasive skin genomics platform, today announced that the Journal of ...
Ladies and gentlemen, thank you for standing by. Welcome to DermTech's Fourth Quarter 2023 Financial Results Call. At this time, all participants are in a listen-only mode. After the speakers' ...
NEW YORK--(BUSINESS WIRE)--WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of DermTech, Inc. (NASDAQ: DMTK) between May 3, 2022 and November 3, 2022, both ...
- Negative predictive value (NPV) higher than 99% regardless of skin type Using follow-up information and biopsy results from a large registry database that also served as the basis for the Company’s ...
DermTech, Inc. (DMTK) is expected to deliver a year-over-year increase in earnings on higher revenues when it reports results for the quarter ended June 2021. This widely-known consensus outlook gives ...
Wall Street expects a year-over-year decline in earnings on higher revenues when DermTech, Inc. (DMTK) reports results for the quarter ended June 2022. While this widely-known consensus outlook is ...
Entering text into the input field will update the search result below Entering text into the input field will update the search result below ...
New York, New York--(Newsfile Corp. - November 28, 2023) - WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of DermTech, Inc. (NASDAQ: DMTK) between May 3, 2022 ...
WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of DermTech, Inc. (NASDAQ: DMTK) between May 3, 2022 and November 3, 2022, both dates inclusive (the "Class ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results